Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Common Stock | 446K | $546K | $1.22 | May 16, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKBA | Akebia Therapeutics, Inc. | May 16, 2023 | 1 | -$67.9K | 4 | May 18, 2023 | SVP, CFO and Treasurer |
AKBA | Akebia Therapeutics, Inc. | Mar 1, 2023 | 2 | -$6.33K | 4 | Mar 3, 2023 | SVP, CFO and Treasurer |
AKBA | Akebia Therapeutics, Inc. | Feb 27, 2023 | 1 | -$6.13K | 4 | Mar 1, 2023 | SVP, CFO and Treasurer |
AKBA | Akebia Therapeutics, Inc. | Jan 31, 2023 | 2 | $0 | 4 | Feb 2, 2023 | SVP, CFO and Treasurer |
AKBA | Akebia Therapeutics, Inc. | Jun 8, 2022 | 2 | $0 | 4 | Jun 10, 2022 | SVP, CFO and Treasurer |
AKBA | Akebia Therapeutics, Inc. | Feb 28, 2022 | 4 | -$17.7K | 4 | Mar 2, 2022 | SVP, CFO and Treasurer |
AKBA | Akebia Therapeutics, Inc. | Sep 30, 2021 | 1 | $0 | 4 | Oct 1, 2021 | SVP, CFO and Treasurer |